Cargando…

Clinical outcomes after permanent polymer or polymer‐free stent implantation in patients with diabetes mellitus: The ReCre8 diabetes substudy

OBJECTIVES: The purpose of this analysis was to compare target‐lesion failure (TLF) of a permanent polymer zotarolimus‐eluting stent (PP‐ZES) versus a polymer‐free amphilimus‐eluting stent (PF‐AES) in diabetics. BACKGROUND: The improvement of outcomes with new‐generation drug‐eluting stent as seen i...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Hemert, Nicole D., Rozemeijer, Rik, Voskuil, Michiel, Stein, Mèra, Frambach, Peter, Rittersma, Saskia Z., Kraaijeveld, Adriaan O., Leenders, Geert E. H., van der Harst, Pim, Agostoni, Pierfrancesco, Stella, Pieter R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Coronary Artery Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540458/ https://www.ncbi.nlm.nih.gov/pubmed/33811730 http://dx.doi.org/10.1002/ccd.29685

Ejemplares similares

One‐year clinical outcomes of patients treated with polymer‐free amphilimus‐eluting stents or zotarolimus‐eluting stents: A propensity‐score adjusted analysis
por: Rozemeijer, Rik, et al.
Publicado: (2019)

Direct comparison of predictive performance of PRECISE-DAPT versus PARIS versus CREDO-Kyoto: a subanalysis of the ReCre8 trial
por: Rozemeijer, R., et al.
Publicado: (2020)

Elastic stent recoil in coronary total occlusions: Comparison of durable‐polymer zotarolimus eluting stent and ultrathin strut bioabsorbable‐polymer sirolimus eluting stent
por: Improta, Riccardo, et al.
Publicado: (2021)

Association of high-density lipoprotein cholesterol with non-fatal cardiac and non-cardiac events: a CANHEART substudy
por: Wijeysundera, Harindra C, et al.
Publicado: (2017)

Observer variability in the assessment of CT coronary angiography and coronary artery calcium score: substudy of the Scottish COmputed Tomography of the HEART (SCOT-HEART) trial
por: Williams, Michelle C, et al.
Publicado: (2015)

Individual patient data analysis of the BIOFLOW study program comparing safety and efficacy of a bioresorbable polymer sirolimus eluting stent to a durable polymer everolimus eluting stent
por: Toelg, Ralph, et al.
Publicado: (2020)

Three‐year clinical outcome of biodegradable hybrid polymer Orsiro sirolimus‐eluting stent and the durable biocompatible polymer Resolute Integrity zotarolimus‐eluting stent: A randomized controlled trial
por: Kim, Soo‐Hyun, et al.
Publicado: (2019)

Comparison of neointimal coverage between ultrathin biodegradable polymer‐coated sirolimus‐eluting stents and durable polymer‐coated everolimus‐eluting stents: 6 months optical coherence tomography follow‐up from the TAXCO study
por: Abhyankar, Atul, et al.
Publicado: (2020)

Comparison of 6‐month vascular healing response after bioresorbable polymer versus durable polymer drug‐eluting stent implantation in patients with acute coronary syndromes: A randomized serial optical coherence tomography study
por: Noguchi, Masahiko, et al.
Publicado: (2021)

Comparison of long‐term clinical outcomes in multivessel coronary artery disease patients treated either with bioresoarbable polymer sirolimus‐eluting stent or permanent polymer everolimus‐eluting stent: 5‐year results of the CENTURY II randomized clinical trial
por: Iñiguez, Andrés, et al.
Publicado: (2019)

Impact of sheath size and hemostasis time on radial artery patency after transradial coronary angiography and intervention in Japanese and non‐Japanese patients: A substudy from RAP and BEAT (Radial Artery Patency and Bleeding, Efficacy, Adverse evenT) randomized multicenter trial
por: Aminian, Adel, et al.
Publicado: (2018)

Safety and efficacy of Everolimus‐Eluting bioabsorbable Polymer‐Coated stent in patients with long coronary lesions: The EVOLVE 48 study
por: Karmpaliotis, Dimitrios, et al.
Publicado: (2021)

Device entrapment during percutaneous coronary intervention
por: Sanz‐Sánchez, Jorge, et al.
Publicado: (2022)

Gender differences in health-related quality of life in patients undergoing coronary angiography
por: Gijsberts, Crystel M, et al.
Publicado: (2015)

Polymer‐free Biolimus‐A9 coated thin strut stents for patients at high bleeding risk 1‐year results from the LEADERS FREE III study
por: Eberli, Franz R., et al.
Publicado: (2021)

Three‐year clinical outcome in all‐comers with “silent” diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug‐eluting stents: From the BIO‐RESORT Silent Diabetes study
por: Ploumen, Eline H., et al.
Publicado: (2019)

Outcomes in patients with a first episode of chest pain undergoing early coronary CT imaging
por: Siegersma, Klaske R, et al.
Publicado: (2022)

Percutaneous coronary intervention for left main stem disease: Impact of diabetes mellitus on mortality
por: Bawamia, Bilal R., et al.
Publicado: (2020)

Three‐year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus‐eluting stent in routine PCI in patients with diabetes mellitus—AIDA sub‐study
por: Kerkmeijer, Laura S.M., et al.
Publicado: (2020)

Long‐term outcome after deferred revascularization due to negative fractional flow reserve in intermediate coronary lesions
por: Weerts, Jerremy, et al.
Publicado: (2020)

Correlation of corrected QT dispersion with the severity of coronary artery disease detected by SYNTAX score in non-diabetic patients with STEMI
por: Helmy, Hatem, et al.
Publicado: (2017)

Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus
por: Noman, Awsan, et al.
Publicado: (2016)

Glycaemic control and excess risk of major coronary events in patients with type 2 diabetes: a population-based study
por: Tancredi, Mauro, et al.
Publicado: (2019)

Risk factors and therapeutic coverage at 6 years in patients with previous myocardial infarction: the CASTUO study
por: Félix-Redondo, Francisco Javier, et al.
Publicado: (2016)

Systematic review and meta-analysis of optimal P2Y(12) blockade in dual antiplatelet therapy for patients with diabetes with acute coronary syndrome
por: Rossington, Jennifer A, et al.
Publicado: (2016)

Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent
por: Jakobsen, Lars, et al.
Publicado: (2022)

Clinical impact of CT coronary angiography without exclusion of small coronary artery segments: a real-world and long-term study
por: Logghe, Yannick, et al.
Publicado: (2020)

Patient preference for radial versus femoral vascular access for elective coronary procedures: The PREVAS study
por: Kok, Marlies M., et al.
Publicado: (2017)

Viability and functional recovery after chronic total occlusion percutaneous coronary intervention
por: Schumacher, Stefan P., et al.
Publicado: (2021)

Differences in risk and costs between prehospital identified low-risk men and women with chest pain
por: Aarts, Goaris W A, et al.
Publicado: (2023)

Serial invasive imaging follow‐up of the first clinical experience with the Magmaris magnesium bioresorbable scaffold
por: Tovar Forero, Maria Natalia, et al.
Publicado: (2019)

Stent underexpansion due to heavy coronary calcification resistant to rotational atherectomy: A case for coronary lithoplasty?
por: Tovar Forero, Maria Natalia, et al.
Publicado: (2019)

Diastolic-systolic velocity ratio to detect coronary stenoses under physiological resting conditions: a mechanistic study
por: de Waard, Guus A, et al.
Publicado: (2019)

Validation of novel 3‐dimensional quantitative coronary angiography based software to calculate fractional flow reserve post stenting
por: Masdjedi, Kaneshka, et al.
Publicado: (2020)

Cardiac Catheterizations in Patients With Prior Coronary Bypass Surgery: Impact of Access Strategy on Short-Term Safety and Long-Term Efficacy Outcomes
por: Groenland, Frederik T., et al.
Publicado: (2021)

Non‐invasive procedural planning using computed tomography‐derived fractional flow reserve
por: Bom, Michiel J., et al.
Publicado: (2020)

Bail out lithotripsy to treat delayed valve‐in‐valve TAVR‐related coronary obstruction
por: Bingen, Brian O., et al.
Publicado: (2022)

Impact of recurrent ischaemic and bleeding events on quality of life in patients with acute coronary syndrome: Insights from the FORCE-ACS registry
por: van der Sangen, Niels M R, et al.
Publicado: (2023)

A hospital‐wide system to ensure rapid treatment time across the entire spectrum of emergency percutaneous intervention
por: Khot, Umesh N., et al.
Publicado: (2015)

International patterns of dual antiplatelet therapy duration after acute coronary syndromes
por: Bueno, Héctor, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5471jf74ag4kof6a5feubeilch